巨子 ICON - 財經股票資訊及專家分析
搜尋 股票

Acer Therapeutics

ACER
最少15分鐘延遲,股票資訊由第三方資訊供應商提供
・Acer Therapeutics - 延遲價格・最後更新於 21/01 12:15
最高位
2.160
最低位
2.150
開市價
--
前收市價
2.200
成交量(千)
0.30
成交額(百萬)
0.01
買入
--
賣出
--
每手股數
--
市值(百萬)
30.77
市盈率
--
息率
--
差價
--
52週高低
5.390 - 1.680
所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

企業資料

公司名稱
Acer Therapeutics
證券代碼
ACER.US
所屬板塊
Biotechnology
公司業務
Acer Therapeutics Inc operates as a pharmaceutical company. Principally, it is focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with a critical unmet medical need. The company's clinical pipeline includes three categories of severe genetic disorders namely EDSIVO for vEDS, and ACER-001 for urea cycle disorders and maple syrup urine disease.
發行量
14310244
公司總部
300 Washington Street, One Gateway Center, Suite 351
公司網址
https://www.acertx.com
公司電郵
info@opexatherapeutics.com
公司電話
+1 844 902-6100
暫無內容

關於

Acer Therapeutics(ACER.US)所屬的行業板塊為Biotechnology。
Acer Therapeutics Inc operates as a pharmaceutical company. Principally, it is focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with a critical unmet medical need. The company's clinical pipeline includes three categories of severe genetic disorders namely EDSIVO for vEDS, and ACER-001 for urea cycle disorders and maple syrup urine disease.
詳細公司背景可參考: https://www.acertx.com